Apr 18, 2020 by David Haen2 Biotechs Battling Against Kidney CancerNew combination trials bring hope for patients and investors.
Apr 17, 2020 by David HaenIs Aimmune Therapeutics a Buy?A recent drug approval, a competitor's setback, and a discounted stock price make Aimmune an intriguing investment.
Apr 15, 2020 by David HaenShould You Buy These 4 Biotech Stocks With Recent Drug Approvals?These companies scored recent drug approvals. It's worth looking into their stocks to see if they're a buy now.
Apr 12, 2020 by David HaenBetter Buy: Alnylam Pharmaceuticals vs. Vir BiotechnologyWill a 14-year head start prove to be an advantage between these biotechs?
Apr 12, 2020 by David HaenIs Galapagos Stock a Buy?Investors may want to own this biotech before its lead drug gets approved.
Apr 10, 2020 by David HaenIs AnaptysBio Stock a Buy?This antibody drug developer can be had for fire-sale prices.
Apr 7, 2020 by David HaenIs Quest Diagnostics a Great Dividend Stock?In turbulent market conditions, some investors find safety in owning stable, dividend-paying companies.
Apr 5, 2020 by David HaenWhy Is Everyone Talking About Amarin Stock?$3 billion in value evaporated into thin air on a judge’s recent decision.
Apr 4, 2020 by David HaenShould You Buy Forty Seven Before Gilead Sciences' Acquisition Closes?The immuno-oncology buyout is set to close this quarter.
Apr 4, 2020 by David HaenIs the End of Quarter Market Run-Up Just Wall Street Dressing the Window?Stocks rose as the quarter drew to a close, but don't get caught thinking the tide has shifted.
Apr 3, 2020 by David HaenShould You Buy These 3 Biotechs Now?These drug developers just released new clinical trial results.
Mar 30, 2020 by David Haen4 Reasons Drug Stocks Are a Buy Right NowDrug developers took center stage as the world looks to these companies to deliver an answer to COVID-19.
Mar 27, 2020 by David HaenBetter Buy: Geron vs. AcceleronIn this David versus Goliath battle, which biotech offers investors a greater return?
Mar 26, 2020 by David HaenTop Drug Stocks Under $5Healthcare bargain hunters can find good values in quality low-priced stocks.
Mar 26, 2020 by David Haen1 Safe-Haven Stock for the Near TermTake advantage of a declining stock price for this soon-to-be-acquired company.
Mar 24, 2020 by David HaenCan Medical Device Stocks Help Rebuild Your Portfolio?Some of the biggest medical device companies' stocks have dropped to attractive prices due to the current COVID-19 pandemic.
Mar 19, 2020 by David Haen3 Cancer Treatment Stocks to Buy Right NowCancer is one of the most competitive -- and lucrative -- areas for biotech investors.
Mar 19, 2020 by David HaenBetter Buy: CRISPR Therapeutics vs. Sangamo BiosciencesWith valuations cut in half, investors should consider these promising gene-editing companies.
Mar 18, 2020 by David HaenBetter Buy: GW Pharmaceuticals vs. Corbus PharmaceuticalsThese cannabinoid-based drug developers offer different risk/reward profiles.
Mar 18, 2020 by David HaenWill COVID-19 Derail New Drugs?Disruptions in clinical trials and delayed regulatory decisions could slow the rate of new drug approvals.
